Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

Cerebrovascular risk factors, including hypertension, smoking, diabetes mellitus, aging, dyslipidemia, and hyperhomocyst(e)inemia are linked to endothelial dysfunction. Endothelial-derived nitric oxide (NO) has inhibitory effects on key processes in atherothrombosis. Although asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, is associated with atherosclerotic disease, there has been no report on association of ADMA with ischemic. stroke. Here we investigated the relation of plasma ADMA, stroke, and homocyst(e)inemia in the elderly. Plasma ADMA and homocyst(e)ine concentration was determined using high-performance liquid chromatography and fluorescence detection. Patients with ischemic stroke had significantly higher concentrations of plasma ADMA than controls (1.85 +/- 1.32 vs. 0.93 +/- 0.32 mu mol/l, P = 0.0001). After adjustment for risk factors, elevated ADMA levels, above 90th percentile of normal controls (greater than or equal to1.43 mu mol/l) was associated with stroke (OR = 6.05, 95% CI; 2.77 - 13.3, P = 0.02). ADMA plasma levels were positively correlated to homocyst(e)ine levels (r = 0.43, P = 0.01). Multiple logistic regression analysis revealed that hyperhomocyst(e)inemia (plasma homocyst(e)ine concentration greater than or equal to 15.0 mu mol/l) was a significant predictor of elevated ADMA level. Altogether, findings indicate that elevated ADMA concentrations are at increased risk for ischemic stroke in the elderly, and may account for increased risk of stroke in patients with hyperhomocyst(e)inemia. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.